Sarcoidosis

Sarcoidosis is a disease of unknown cause that leads to inflammation. It can affect various organs in the body. Normally, your immune system defends your body against foreign or harmful substances. For example, it sends special cells to protect organs that are in danger.
What is Sarcoidosis?

Sarcoidosis, also known as sarcoid or Besnier-Boeck disease, is a health condition involving the formation of small nodules known as granulomas at various sites of the body. It is thought to occur due to inflammatory processes and may have a genetic link, although the exact cause in unknown.

Read More

Overview

Feature Articles

Latest Sarcoidosis News and Research

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

Free clinics try to fill gaps as COVID sweeps away job-based insurance

Free clinics try to fill gaps as COVID sweeps away job-based insurance

ATS publishes first official clinical practice guidelines for sarcoidosis

ATS publishes first official clinical practice guidelines for sarcoidosis

New statement highlights occupational burden of non-cancerous lung diseases

New statement highlights occupational burden of non-cancerous lung diseases

Researchers identify genetic component involved in development of familial sarcoidosis

Researchers identify genetic component involved in development of familial sarcoidosis

Microglia play vital role in regulating neuroinflammation, research shows

Microglia play vital role in regulating neuroinflammation, research shows

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

Yale researchers use arthritis medication to treat patient with disfiguring sarcoidosis

Middle-aged adults with lung disease may have greater risk of dementia later in life

Middle-aged adults with lung disease may have greater risk of dementia later in life

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Gram-negative bacteria found to be risk factor for worse outcomes in hospitalized ILD patients

Gram-negative bacteria found to be risk factor for worse outcomes in hospitalized ILD patients

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

ERS collaborates with 3D Systems to provide simulation equipment for EBUS training centers

ERS collaborates with 3D Systems to provide simulation equipment for EBUS training centers

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Researchers create revolutionary model to study pulmonary diseases

Researchers create revolutionary model to study pulmonary diseases

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients